ID: ALA5270687

Max Phase: Preclinical

Molecular Formula: C43H69ClN2O4

Molecular Weight: 677.03

Associated Items:

Representations

Canonical SMILES:  CC1(C)CCC[C@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)CC[C@H](OC(=O)CN5CCN(Cc6ccccc6)CC5)C(C)(C)[C@@H]4CC[C@]23C)O1.Cl

Standard InChI:  InChI=1S/C43H68N2O4.ClH/c1-38(2)18-12-19-43(8,49-38)31-15-21-42(7)37(31)32(46)27-34-40(5)20-17-35(39(3,4)33(40)16-22-41(34,42)6)48-36(47)29-45-25-23-44(24-26-45)28-30-13-10-9-11-14-30;/h9-11,13-14,31-35,37,46H,12,15-29H2,1-8H3;1H/t31-,32+,33-,34+,35-,37-,40-,41+,42+,43+;/m0./s1

Standard InChI Key:  ROAHVFQVRBXEOP-XXKMXQRPSA-N

Associated Targets(non-human)

PC-12 7051 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 677.03Molecular Weight (Monoisotopic): 676.5179AlogP: 8.11#Rotatable Bonds: 6
Polar Surface Area: 62.24Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 7.37CX LogP: 7.53CX LogD: 7.25
Aromatic Rings: 1Heavy Atoms: 49QED Weighted: 0.31Np Likeness Score: 1.55

References

1. Pang L, Li J, Liu Z, Quan YS, Sui HH, Jia Y, Chen F, Lee JJ, Liu P, Quan ZS, Shen QK, Guo HY..  (2022)  In vitro and in vivo biological evaluation of newly synthesized multi-target 20(R)-panaxadiol derivatives for treating Alzheimer's disease.,  244  [PMID:36306540] [10.1016/j.ejmech.2022.114825]

Source